CEO Kersten Geert R Buys 100,000 CEL‑SCI Shares Amid 9.8% Weekly Sell‑Off, Signals Bullish Outlook for Struggling Biotech
CEO Kersten Geert’s recent buy of 100k CEL‑SCI shares signals confidence amid volatility, offering investors insight into the company’s future.
3 minutes to read